CVE-2026-44115: high-severity vulnerability in OpenClaw
OpenClaw < 2026.4.22 - Shell Expansion Bypass in Unquoted Heredocs via Exec Allowlist
Published · Updated
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 8.7epss 0.6%
exploitation probability
0.6%top 53% of all CVEs
observed exploitation
nono source reports it
OpenClaw before 2026.4.22 contains an exec allowlist analysis vulnerability allowing shell expansion hiding in unquoted heredoc bodies. Attackers can bypass allowlist validation by embedding shell expansion tokens in heredoc bodies to execute unapproved commands at runtime.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Affected products
OpenClaw · OpenClawRelated CVEs — OpenClaw
In the same product, most dangerous first.
CVE-2026-25253HIGHCVE-2026-25253EPSS 24.4%CVE-2026-32917CRITICALOpenClaw < 2026.3.13 - Remote Command Injection via Unsanitized iMessage Attachment Paths in SCPEPSS 3.2%CVE-2026-53822HIGHOpenClaw < 2026.5.18 - Command Argument Modification via Shell Wrapper Between Approval and ExecutionEPSS 2.0%CVE-2026-32052MEDIUMOpenClaw < 2026.2.24 - Hidden Command Execution via Shell-Wrapper Positional argv CarriersEPSS 1.6%CVE-2026-44998LOWOpenClaw < 2026.4.20 - Tool Policy Bypass via Bundled MCP/LSP ToolsEPSS 1.2%CVE-2026-44109CRITICALOpenClaw < 2026.4.15 - Authentication Bypass in Feishu Webhook and Card-Action ValidationEPSS 1.1%